Papers using
Plk1
antibodies
Protein phosphatase 6 regulates mitotic spindle formation by controlling the T-loop phosphorylation state of Aurora A bound to its activator TPX2Gruneberg Ulrike et al., In The Journal of Cell Biology, 2009
... University of Liverpool, England, UK), mouse anti-Myc (clone 9E10), rabbit anti-Myc (both from Sigma-Aldrich), mouse anti-Plk1 (Santa Cruz Biotechnology, Inc.), mouse anti-PPP2CA (BD), ... more suppliers
Papers on
Plk1
Emerging mitotic inhibitors for non-small cell carcinoma.Gridelli et al., Napoli, Italy. In Expert Opin Emerg Drugs, 31 Mar 2013
Furthermore, the identification of novel mitotic drug targets other than microtubules has gained recently much attention, such as aurora kinases, Polo-like kinase1 (PLK1), kinesin spindle protein (KSP), and centromeric protein E (CENPE).
Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity.Dong et al., Changsha, China. In Carcinogenesis, Nov 2012
Moreover, the regulatory effect of miRNA in radiosensitivity can be enhanced when interacting with various key molecules, including H2AX, BRCA1, ATM, DNA-PK, RAD51, Chk1, Cdc25A, p53, PLK1, HIF-1 and VEGF, which are involved in these processes.
A guide to picking the most selective kinase inhibitor tool compounds for pharmacological validation of drug targets.Zaman et al., Oss, Netherlands. In Br J Pharmacol, Jun 2012
In addition, we recommend which inhibitors to use for studying the biology of the 20 most investigated kinases that are clinically relevant: Abl (ABL1), AKT1, ALK, Aurora A/B, CDKs, MET, CSF1R (FMS), EGFR, FLT3, ERBB2 (HER2), IKBKB (IKK2), JAK2/3, JNK1/2/3 (MAPK8/9/10), MEK1/2, PLK1, PI3Ks, p38α (MAPK14), BRAF, SRC and VEGFR2 (KDR).
Systematic discovery of TLR signaling components delineates viral-sensing circuits.Hacohen et al., Cambridge, United States. In Cell, 2011
In particular, we find that Polo-like kinases (Plk) 2 and 4 are essential components of antiviral pathways in vitro and in vivo and activate a signaling branch involving a dozen proteins, among which is Tnfaip2, a gene associated with autoimmune diseases but whose role was unknown.
Shared and separate functions of polo-like kinases and aurora kinases in cancer.Medema et al., Utrecht, Netherlands. In Nat Rev Cancer, 2010
Within the polo-like kinase family, the emphasis for targeted therapies has been on polo-like kinase 1 (PLK1), and in the aurora kinase family drugs have been developed to specifically target aurora kinase A (AURKA; also known as STK6) and/or aurora kinase B (AURKB; also known as STK12).
More papers using
Plk1
antibodies
Host-pathogen interactions: leukocyte phagocytosis and associated sequelaePotempa J S et al., In Cell Death & Disease, 2001
... anti-SR-A (clone SRA-E5, Trans Genic Inc., Kobe, Japan) and anti-LOX-1, anti-MARCO and anti-CD36 (clones 23C11, PLK1 and FA6-152, respectively, Cell Sciences, Canton, MA, USA) ...